Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA, is an assistant professor in the University of Arizona College of Medicine--Tucson, Division of Cardiology. She is presenting a talk at the American Heart Association (AHA) Scientific Sessions, "COVID-19 as a Catalyst to Address Disparities in Cardiovascular Outcomes and Inequities in Cardiovascular Care Delivery.”
Transcript:
Can you discuss the major themes you will be addressing in your talk, “COVID-19 as a Catalyst to Address Disparities in Cardiovascular Outcomes and Inequities in Cardiovascular Care Delivery”?
In this session, we're going to be addressing how this pandemic has really devastated these populations: populations of color and women, beyond even heart failure, but with cardiovascular disease. I think some of the key things that we've learned are that there are systematic inequities that are progressively worsening to, potentially, the point of no return. It's imperative that we start to take the steps to address them and correct them if we don't want to continue just talking about the disparities year after year.
In this talk, I address some of the current issues that are present with cardiovascular disease. It's the leading cause of death of all people groups, but it's disproportionately killing people of color, particularly Black individuals. There's still a lot of issues with receipts and allocation of vaccines with the ability to work from home, with the opportunities to excel at a person's workplace, and how all these issues impact one's health and one's cardiovascular health. The imperative is on the community, on our policymakers, and our stakeholders to start to address the root cause of these problems—the structural racism, the social determinants of health and bias—if we truly want to change the way that things are going, if we want to make things better, if we want to end this pandemic. That presentation focuses on this.
Before COVID-19, both the AHA and ACC meetings featured discussions on the fairness of CMS quality measures. Discussions have centered on whether measures in heart failure account for disparities; as a result, the measures may penalize safety net hospitals that care for a higher share of patients who are socially and economically disadvantaged. What has been your experience?
There's obvious inequities, obvious issues with the policies and structures that are currently in place that need to be looked at a little bit differently. I am in favor of using tools like implementation science, where we look at these policies and see whether or not it changed and did what it was intended to do, and if it did not, to obtain the appropriate feedback to see how do we change it, how do we make the next iterations so that it can do what it's intended to do. I think there's an abundance of data that show things like with the penalties for heart failure, rehospitalization, that a number of changes are needed if we're going to try to get the policy to do what was intended, which is to improve care, to improve access to care. Unfortunately, we know with this policy, it's actually resulted in reduction in hospitalizations but increase in mortality.
We have to—with any policy that's put in place—make sure that it's, 1, doing what it's intended to do, and, 2, we have to really care about equity and decide that equity is a priority, meaning that it doesn't matter what your race or sex is, you're going to get the care that you deserve. That's going to require looking at things from a racial lens because we live in a racist society. I believe that there is intent in the desire to make these changes, but a lot of additional work is needed to actually put them into place. With the education of the public and increased awareness, I hope that individuals will be willing to decide that they're going to do the work to make these changes, to speak up about things that maybe don't impact them but know that impacts their fellow human being, and willing to be uncomfortable so that we can make sure that everyone gets an equitable opportunity to the care that they need and deserve.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More